Report overview
Molecular imaging is a new biomedical research discipline which enables the quantification, visualization, and characterization of biologic processes taking place at the cellular and subcellular levels. Molecular imaging plays a very important role in diagnosis of early assessment, risk stratification, and follow-up of patients with neurological diseases. Imaging agents are the substances designed to improve the imaging output of specific organs, physiological functions, tissues and diseases. Molecular imaging agents are small molecules, peptides, engineered proteins, aptamers and nanoparticles. The main purpose of a molecular imaging agent is to cross-examine and report back about a specific target of interest during the course of a molecular imaging study.
This report aims to provide a comprehensive presentation of the global market for Molecular Imaging Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Imaging Agents. This report contains market size and forecasts of Molecular Imaging Agents in global, including the following market information:
Global Molecular Imaging Agents Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global Molecular Imaging Agents Market Sales, 2018-2023, 2024-2035, (K MT)
Global top five Molecular Imaging Agents companies in 2022 (%)
The global Molecular Imaging Agents market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Based on types, the global molecular imaging agents market is segmented into small molecules, peptides, engineered protein fragments, aptamers, nanoparticles and others. Amongst all, peptides have emerged as a very important type of molecular imaging agents. Based on application, the global molecular imaging agents market is segmented into oncology, cardiology, gastrointestinal disorders and neurology disoeder. Similarly, based on end user, the market is segmented into, hospitals and clinics, ambulatory surgical centers, diagnostic & imaging centers, and others. Diagnostic & imaging centers are expected to hold maximum share in the market due to the ease of availability of medication.
We surveyed the Molecular Imaging Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Imaging Agents Market, by Type, 2018-2023, 2024-2035 ($ Millions) & (K MT)
Global Molecular Imaging Agents Market Segment Percentages, by Type, 2022 (%)
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Global Molecular Imaging Agents Market, by Application, 2018-2023, 2024-2035 ($ Millions) & (K MT)
Global Molecular Imaging Agents Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
Global Molecular Imaging Agents Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions) & (K MT)
Global Molecular Imaging Agents Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Imaging Agents revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Molecular Imaging Agents revenues share in global market, 2022 (%)
Key companies Molecular Imaging Agents sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Molecular Imaging Agents sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
General Electric
Bracco Diagnostic
Eisai
Guerbet
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Imaging Agents, market overview.
Chapter 2: Global Molecular Imaging Agents market size in revenue and volume.
Chapter 3: Detailed analysis of Molecular Imaging Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Imaging Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Molecular Imaging Agents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
